Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
deals
3
×
gene therapy
life sciences
national blog main
national top stories
zolgensma
3
×
boston blog main
boston top stories
bristol-myers squibb
cancer
clinical trials
crispr
national
new york blog main
new york top stories
novartis
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
startups
abbvie
acquisitions
adalimumab (humira)
adeno-associated virus
aducanumab
aduro biotech
advanced therapies
affordable care act
alexandria venture investments
alez azar
altitude life science ventures
alzheimer's disease
american society of gene and cell therapy
antibiotics
arch venture partners
atmp
avexis
axial spondyloarthritis
What
gene
remains
therapy
access
advanced
approval
bio
biogen’s
biopharmaceutical
capacity
car
cell
companies
consolidation
convo
crispr
crude
cutting
despite
drug
earlier
edge
effects
encoded
failures
falcon
focus
help
illumina’s
lasting
limited
limits
littered
long
medicine
milestones
nabs
nash
new
news
Language
unset
Current search:
zolgensma
×
deals
×
biotech
×
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More